Description
RADIOPHARMACEUTICALS - VASNHCS
First action · last action
2014-10-01 · 2016-03-10
Transactions
2
First transaction's obligation
$379,962
Base + all options value (sum of deltas)
$217,167
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-01+$379,962= $379,962
- Mod P000012016-03-10-$162,795= $217,167
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-01 | +$379,962 | $379,962 | RADIOPHARMACEUTICALS - VASNHCS |
| Mod P00001· FUNDING ONLY ACTION | 2016-03-10 | −$162,795 | $217,167 | RADIOPHARMACEUTICALS - VASNHCS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ULTMAJ6SMBK6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26126P0997 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $247,204 | FY2026 |
| 36C26125D0018 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36C26125N0173 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $252,379 | FY2025 |
| 36C26124N0126 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $244,300 | FY2024 |
| 36C26123N0136 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $206,116 | FY2023 |
| 36C26122N0284 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $180,655 | FY2022 |
Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26116F1413 | CSL BEHRING L.L.C. | 261-NETWORK CONTRACT OFFICE 21 | $12,789 | FY2016 |
| VA26116F1408 | CSL BEHRING L.L.C. | 261-NETWORK CONTRACT OFFICE 21 | $10,733 | FY2016 |
| VA26116F1244 | SEQIRUS USA INC | 261-NETWORK CONTRACT OFFICE 21 | $31,450 | FY2016 |
| VA26116F1240 | SEQIRUS USA INC | 261-NETWORK CONTRACT OFFICE 21 | $7,234 | FY2016 |
| VA26116F1213 | SEQIRUS USA INC | 261-NETWORK CONTRACT OFFICE 21 | $62,900 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26114C0219_3600_-NONE-_-NONE- · retrieved 2026-09-26.